We have funding for a joint project between the group of Isabelle Lamsoul and Pierre G. Lutz at the Toulouse Institute for Infectious and Inflammatory Diseases (Infinity) and a pharmaceutical company aimed at modulating immune cell responses for therapeutic purposes.
3-years employment planned to start in December 2023 or upon agreement. Salary will be accordingly to the Inserm salary scale
The project is dedicated to the understanding of ubiquitylation/deubiquitylation events in immunity and disease to identify novel therapeutic targets for precision medicine.
